Literature DB >> 1380990

Influence of testicular carcinoma on ipsilateral spermatogenesis.

G T Ho1, H Gardner, W C DeWolf, K R Loughlin, A Morgentaler.   

Abstract

A histological review of radical orchiectomy specimens was performed to assess the impact of testicular cancer on spermatogenesis. Slides from 28 patients with testicular cancer were available for review, consisting of 14 pure seminomas, 12 embryonal carcinomas and 2 mixed tumors. For each specimen tubules adjacent (less than 3 mm.) to the tumor and distant (more than 3 mm.) from the tumor were evaluated. This study indicates that marked impairment of ipsilateral spermatogenesis is associated with testicular carcinoma, particularly in the vicinity of the tumor. The quality of distant spermatogenesis appears to be influenced by tumor type and not by elevation of known serum tumor markers, such as human chorionic gonadotropin and alpha-fetoprotein, nor by the presence of carcinoma in situ.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1380990     DOI: 10.1016/s0022-5347(17)36732-0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Risk of testicular cancer in subfertile men: case-control study.

Authors:  H Møller; N E Skakkebaek
Journal:  BMJ       Date:  1999-02-27

2.  Microscopic testicular sperm extraction or post-operative sperm reversal in functional Leydig cell tumor: case report.

Authors:  Zhongyan Liang; Zhanwang He; Chong Chen; Fengbin Zhang; Jingping Li; Jinggen Wu
Journal:  Transl Androl Urol       Date:  2019-10

3.  Inhibin B: are modified ranges needed for orchiectomised testicular cancer patients?

Authors:  Alessandra Petrozzi; Francesco Pallotti; Marianna Pelloni; Antonella Anzuini; Antonio Francesco Radicioni; Andrea Lenzi; Donatella Paoli; Francesco Lombardo
Journal:  Asian J Androl       Date:  2019 Jul-Aug       Impact factor: 3.285

Review 4.  Fatherhood and Sperm DNA Damage in Testicular Cancer Patients.

Authors:  Donatella Paoli; Francesco Pallotti; Andrea Lenzi; Francesco Lombardo
Journal:  Front Endocrinol (Lausanne)       Date:  2018-09-13       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.